158 related articles for article (PubMed ID: 35422085)
21. Prognostic significance of forkhead box M1 (FoxM1) expression and antitumour effect of FoxM1 inhibition in melanoma.
Ito T; Kohashi K; Yamada Y; Maekawa A; Kuda M; Furue M; Oda Y
Histopathology; 2016 Jul; 69(1):63-71. PubMed ID: 26619071
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of FoxM1 by MnSOD Overexpression Contributes to Cancer Stem-Like Cell Characteristics in the Lung Cancer H460 Cell Line.
Fu Z; Cao X; Yang Y; Song Z; Zhang J; Wang Z
Technol Cancer Res Treat; 2018 Jan; 17():1533033818789635. PubMed ID: 30111255
[TBL] [Abstract][Full Text] [Related]
23. FoxM1 inhibition enhances chemosensitivity of docetaxel-resistant A549 cells to docetaxel via activation of JNK/mitochondrial pathway.
Wang K; Zhu X; Zhang K; Zhu L; Zhou F
Acta Biochim Biophys Sin (Shanghai); 2016 Sep; 48(9):804-9. PubMed ID: 27521795
[TBL] [Abstract][Full Text] [Related]
24. The transcription factor FOXM1 is a cellular target of the natural product thiostrepton.
Hegde NS; Sanders DA; Rodriguez R; Balasubramanian S
Nat Chem; 2011 Aug; 3(9):725-31. PubMed ID: 21860463
[TBL] [Abstract][Full Text] [Related]
25. FoxM1-mediated RFC5 expression promotes temozolomide resistance.
Peng WX; Han X; Zhang CL; Ge L; Du FY; Jin J; Gong AH
Cell Biol Toxicol; 2017 Dec; 33(6):527-537. PubMed ID: 28185110
[TBL] [Abstract][Full Text] [Related]
26. TRIM6 promotes colorectal cancer cells proliferation and response to thiostrepton by TIS21/FoxM1.
Zheng S; Zhou C; Wang Y; Li H; Sun Y; Shen Z
J Exp Clin Cancer Res; 2020 Jan; 39(1):23. PubMed ID: 31992359
[TBL] [Abstract][Full Text] [Related]
27. Aurora kinase A stabilizes FOXM1 to enhance paclitaxel resistance in triple-negative breast cancer.
Yang N; Wang C; Wang J; Wang Z; Huang D; Yan M; Kamran M; Liu Q; Xu B
J Cell Mol Med; 2019 Sep; 23(9):6442-6453. PubMed ID: 31359594
[TBL] [Abstract][Full Text] [Related]
28. Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells.
Ahmed M; Hussain AR; Siraj AK; Uddin S; Al-Sanea N; Al-Dayel F; Al-Assiri M; Beg S; Al-Kuraya KS
Mol Cancer; 2015 Jul; 14():131. PubMed ID: 26159723
[TBL] [Abstract][Full Text] [Related]
29. Forkhead Box Protein M1 Promotes Nasopharyngeal Carcinoma Cell Tumorigenesis Possibly via the Wnt/β-Catenin Signaling Pathway.
Yu C; Chen H; Zhao Y; Zhang Y
Med Sci Monit; 2021 Dec; 27():e931970. PubMed ID: 34911926
[TBL] [Abstract][Full Text] [Related]
30. FLIP: A Targetable Mediator of Resistance to Radiation in Non-Small Cell Lung Cancer.
McLaughlin KA; Nemeth Z; Bradley CA; Humphreys L; Stasik I; Fenning C; Majkut J; Higgins C; Crawford N; Holohan C; Johnston PG; Harrison T; Hanna GG; Butterworth KT; Prise KM; Longley DB
Mol Cancer Ther; 2016 Oct; 15(10):2432-2441. PubMed ID: 27474150
[TBL] [Abstract][Full Text] [Related]
31. Up-regulation of FOXM1 by E6 oncoprotein through the MZF1/NKX2-1 axis is required for human papillomavirus-associated tumorigenesis.
Chen PM; Cheng YW; Wang YC; Wu TC; Chen CY; Lee H
Neoplasia; 2014 Nov; 16(11):961-71. PubMed ID: 25425970
[TBL] [Abstract][Full Text] [Related]
32. Aberrantly high activation of a FoxM1-STMN1 axis contributes to progression and tumorigenesis in FoxM1-driven cancers.
Liu J; Li J; Wang K; Liu H; Sun J; Zhao X; Yu Y; Qiao Y; Wu Y; Zhang X; Zhang R; Yang A
Signal Transduct Target Ther; 2021 Feb; 6(1):42. PubMed ID: 33526768
[TBL] [Abstract][Full Text] [Related]
33. The forkhead box M1 (FOXM1) expression and antitumor effect of FOXM1 inhibition in malignant rhabdoid tumor.
Shibui Y; Kohashi K; Tamaki A; Kinoshita I; Yamada Y; Yamamoto H; Taguchi T; Oda Y
J Cancer Res Clin Oncol; 2021 May; 147(5):1499-1518. PubMed ID: 33221995
[TBL] [Abstract][Full Text] [Related]
34. Expression of Forkhead box M1 in soft tissue leiomyosarcoma: Clinicopathologic and in vitro study using a newly established cell line.
Maekawa A; Kohashi K; Setsu N; Kuda M; Iura K; Ishii T; Matsunobu T; Nakatsura T; Iwamoto Y; Oda Y
Cancer Sci; 2016 Jan; 107(1):95-102. PubMed ID: 26560505
[TBL] [Abstract][Full Text] [Related]
35. Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer.
Weiler SME; Pinna F; Wolf T; Lutz T; Geldiyev A; Sticht C; Knaub M; Thomann S; Bissinger M; Wan S; Rössler S; Becker D; Gretz N; Lang H; Bergmann F; Ustiyan V; Kalin TV; Singer S; Lee JS; Marquardt JU; Schirmacher P; Kalinichenko VV; Breuhahn K
Gastroenterology; 2017 Jun; 152(8):2037-2051.e22. PubMed ID: 28249813
[TBL] [Abstract][Full Text] [Related]
36. Thiostrepton inhibits growth and induces apoptosis by targeting FoxM1/SKP2/MTH1 axis in B-precursor acute lymphoblastic leukemia cells.
Kuttikrishnan S; Prabhu KS; Khan AQ; Alali FQ; Ahmad A; Uddin S
Leuk Lymphoma; 2021 Dec; 62(13):3170-3180. PubMed ID: 34369229
[TBL] [Abstract][Full Text] [Related]
37. Targeting FOXM1 Improves Cytotoxicity of Paclitaxel and Cisplatinum in Platinum-Resistant Ovarian Cancer.
Westhoff GL; Chen Y; Teng NNH
Int J Gynecol Cancer; 2017 Oct; 27(8):1602-1609. PubMed ID: 28692634
[TBL] [Abstract][Full Text] [Related]
38. FOXM1-Mediated Regulation of Reactive Oxygen Species and Radioresistance in Oral Squamous Cell Carcinoma Cells.
Takeshita H; Yoshida R; Inoue J; Ishikawa K; Shinohara K; Hirayama M; Oyama T; Kubo R; Yamana K; Nagao Y; Gohara S; Sakata J; Nakashima H; Matsuoka Y; Nakamoto M; Hirayama M; Kawahara K; Takahashi N; Hirosue A; Kuwahara Y; Fukumoto M; Toya R; Murakami R; Nakayama H
Lab Invest; 2023 May; 103(5):100060. PubMed ID: 36801643
[TBL] [Abstract][Full Text] [Related]
39. FOXM1 Variant Contributes to Gefitinib Resistance via Activating Wnt/β-Catenin Signal Pathway in Patients with Non-Small Cell Lung Cancer.
Guan S; Chen X; Chen Y; Xie W; Liang H; Zhu X; Yang Y; Fang W; Huang Y; Zhao H; Zhuang W; Liu S; Huang M; Wang X; Zhang L
Clin Cancer Res; 2022 Sep; 28(17):3770-3784. PubMed ID: 35695863
[TBL] [Abstract][Full Text] [Related]
40. miR-149 suppresses human non-small cell lung cancer growth and metastasis by inhibiting the FOXM1/cyclin D1/MMP2 axis.
Zhao L; Liu L; Dong Z; Xiong J
Oncol Rep; 2017 Dec; 38(6):3522-3530. PubMed ID: 29130108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
